Monopar Therapeutics Inc
MNPR
$69.27-3.52%
End of day · as of Oct 18, 2026, 4:15 AM ET
Mkt cap
$431.35M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-2.20
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.54
Div yield
N/A
Sector
Healthcare
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported MNPR revenue for 2025-12-31 was $0. Net income was -$13.7M. MNPR currently screens at market cap $431.4M.
Use this MNPR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MNPR income, balance, and cash tables.
Monopar Therapeutics Inc (MNPR) is a biotechnology company in the Healthcare sector.
Latest cached Monopar Therapeutics Inc (MNPR) net income for Dec 31, 2025 was -$13.7M. Statements: https://lician.com/financials/mnpr
Monopar Therapeutics Inc (MNPR) market capitalization is $431.4M on the latest cached snapshot.
Monopar Therapeutics Inc (MNPR) cached previous close $71.80; day range $69.27 – $71.01; volume 141,433. Session quote: https://lician.com/quote/mnpr
Monopar Therapeutics Inc (MNPR) latest cached earnings event is "MNPR earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MNPR filing is 8-K · Aug 12, 2026. Filings: https://lician.com/sec/mnpr